Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Federal Trade Commission
Dow
US Department of Justice
Moodys
US Army
Chubb
QuintilesIMS
Accenture

Generated: May 22, 2018

DrugPatentWatch Database Preview

Ceftibuten dihydrate - Generic Drug Details

or, see our see our flat-rate plans

« Back to Dashboard

What are the generic sources for ceftibuten dihydrate and what is the scope of ceftibuten dihydrate patent protection?

Ceftibuten dihydrate
is the generic ingredient in one branded drug marketed by Si Pharms and is included in two NDAs. Additional information is available in the individual branded drug profile pages.

One supplier is listed for this compound.
Summary for ceftibuten dihydrate
Pharmacology for ceftibuten dihydrate
Synonyms for ceftibuten dihydrate
(6R,7R)-7-((Z)-2-(2-Aminothiazol-4-yl)-4-carboxybut-2-enamido)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid dihydrate
(6R,7R)-7-[[(E)-2-(2-amino-1,3-thiazol-4-yl)-5-hydroxy-5-oxopent-2-enoyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid dihydrate
(6R,7R)-7-[[(Z)-2-(2-amino-1,3-thiazol-4-yl)-5-hydroxy-5-oxopent-2-enoyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid dihydrate
(6R,7R)-7-[[(Z)-2-(2-amino-4-thiazolyl)-4-carboxy-1-oxobut-2-enyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid dihydrate
(6R,7R)-7-[[(Z)-2-(2-aminothiazol-4-yl)-4-carboxy-but-2-enoyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid dihydrate
(6R,7R)-7-[[(Z)-2-(2-azanyl-1,3-thiazol-4-yl)-5-oxidanyl-5-oxidanylidene-pent-2-enoyl]amino]-8-oxidanylidene-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid dihydrate
(6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-4-carboxybut-2-enoyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid--water (1/2)
081C348
118081-34-8
62F4443RWP
7beta-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-4-carboxybut-2-enoyl]amino}-3,4-didehydrocepham-4-carboxylic acid--water(1/2)
A803878
AC1NQZPM
AC1OCD5C
AK326205
AKOS015895926
AKOS025149353
AKOS030241321
AN-6406
API0000453
BC201376
C15H14N4O6S2.2H2O
Cedax (TN)
Ceftibuten (dihydrate)
CEFTIBUTEN 2-HYDRATE
Ceftibuten hydrate
Ceftibuten hydrate (JP17)
ceftibuten.2H2O
CHEBI:34618
CS-4518
CTK8F0745
D02121
HE068843
HE299817
HY-B0698A
I06-1263
Isocef
J-003702
LS-186637
MFCD08141796
MolPort-006-167-795
MolPort-044-724-661
O441
RT-011967
SCHEMBL1236807
SCHEMBL159144
Seftem
Seftem (TN)
UNII-62F4443RWP

US Patents and Regulatory Information for ceftibuten dihydrate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Si Pharms CEDAX ceftibuten dihydrate CAPSULE;ORAL 050685-002 Dec 20, 1995 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Si Pharms CEDAX ceftibuten dihydrate FOR SUSPENSION;ORAL 050686-002 Dec 20, 1995 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Si Pharms CEDAX ceftibuten dihydrate FOR SUSPENSION;ORAL 050686-001 Dec 20, 1995 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

Expired US Patents for ceftibuten dihydrate

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Si Pharms CEDAX ceftibuten dihydrate FOR SUSPENSION;ORAL 050686-002 Dec 20, 1995 ➤ Sign Up ➤ Sign Up
Si Pharms CEDAX ceftibuten dihydrate CAPSULE;ORAL 050685-002 Dec 20, 1995 ➤ Sign Up ➤ Sign Up
Si Pharms CEDAX ceftibuten dihydrate CAPSULE;ORAL 050685-002 Dec 20, 1995 ➤ Sign Up ➤ Sign Up
Si Pharms CEDAX ceftibuten dihydrate FOR SUSPENSION;ORAL 050686-001 Dec 20, 1995 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
US Department of Justice
Cantor Fitzgerald
McKesson
Chubb
Deloitte
Baxter
Johnson and Johnson
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.